In our MTB-IGFIR transgenic model [23,24], Cav-1 was found to be expressed in adipocytes and smooth muscle cells in the mammary gland but the cells of mammary tumors induced by IGF-IR overexpression expressed considerably less Cav-1. This evidence concerns the gene IGF1R and breast cancer.